Related Experiment Videos
Developmental changes of caffeine elimination in infancy.
G Pons1, O Carrier, M O Richard
1Département de Pharmacologie Périnatale et Pédiatrique, Hôpital Saint-Vincent de Paul, Université René Descartes, Paris, France.
Developmental Pharmacology and Therapeutics
|January 1, 1988
Summary
Caffeine citrate dosing for apnea in neonates and infants requires careful adjustment based on age. Monitoring plasma concentrations is essential to ensure safe and effective treatment, with recommended intervals varying by postnatal age.
Area of Science:
- Neonatal pharmacology
- Pediatric pharmacokinetics
Background:
- Apnea is a common respiratory issue in neonates and infants.
- Caffeine citrate is frequently used to manage apnea in this population.
- Individual variability in drug metabolism necessitates tailored dosing strategies.
Purpose of the Study:
- To establish age-dependent dosing guidelines for caffeine citrate in neonates and infants.
- To determine optimal dosing intervals to maintain therapeutic caffeine plasma concentrations.
- To emphasize the importance of therapeutic drug monitoring for caffeine therapy.
Main Methods:
- Plasma samples were collected at various time points after dosing in neonates and infants.
- Caffeine plasma concentrations were quantified using High-Performance Liquid Chromatography (HPLC).
- Pharmacokinetic parameters (half-life, clearance) were analyzed in relation to gestational and postnatal age.
Main Results:
- Caffeine elimination half-life and clearance showed significant correlations with gestational and postnatal age.
- A plateau in caffeine metabolism was observed around the second trimester of postnatal life.
- Age-specific dosing intervals (24, 12, 8, and 6 hours) and doses (2-10 mg/kg) were proposed.
Conclusions:
- Age-dependent pharmacokinetic variability significantly impacts caffeine citrate dosing in neonates and infants.
- The derived dosing regimen aims to maintain therapeutic caffeine plasma levels (7.5-14.5 mg/l).
- Mandatory monitoring of caffeine plasma concentrations is crucial for safe and effective treatment in infants.